The National Immunisation Advisory Committee (NIAC) has given the go-ahead for the single-dose Johnson & Johnson vaccine while restrictions on the AstraZeneca vaccine are eased.
The administering of the Johnson & Johnson vaccine is to begin this week according to the HSE. This follows fears that the J&J vaccine would have been subject to severe restrictions following reports of post-vaccination blood clots.
The vaccination will be made available for those over 50 which is to help speed up the vaccine rollout. The vaccine will also be made available for those under the age of 50 if no other vaccine is available to them or for people who are living in difficult to reach communities.
Chief Medical Officer Dr Tony Holohan is to consider the advice before briefing the government.